Sjögren's Syndrome News
- ACR 2020 Sjögren’s Symptom Clusters May Identify Treatment Options
- Combination Leflunomide-Hydroxychloroquine Promising for Sjogren's Syndrome
- Iscalimab Promising for Sjogren's Syndrome
- ACR 2019 The Trick of Treating Cancer in Autoimmune Diseases
- Findings That Led to $183 Million Drug Development Deal Questioned
- Early-Onset Sjögren's Linked to More Severe Disease
- Another AE Identified With Checkpoint Inhibitors
- Cancer, Autoimmune Disorders Linked to Postsurgery GBS
- New Guidance on Managing Sjogren's Rheumatologic Problems
- Autoimmune Diseases Common in Patients With Vitiligo
- Pediatric Cancer Survivors at High Risk for Autoimmune Disease
- New Name, Diagnostic Criteria for Neuromyelitis Optica
- Varying Tear Osmolarity Readings May Be Hard to Interpret
- Sjogren's: Hydroxychloroquine No Better Than Placebo
- EULAR Increased Cardiovascular Risk in Sjögren's Syndrome
- Ultrasound Improves Sjogren's Syndrome Classification
- Support for Autoimmune-Epilepsy Link
- Rituximab Disappoints in Sjogren Syndrome
- Autoantibodies May Precede Sjogren's Symptoms by Years
- Rituximab in Primary Sjogren's Syndrome